Cooper Consumer Health signed a licensing agreement with Esserre to introduce Armolipid Cholesterol Plus, a new-generation formula developed to support proactive cholesterol management.
Published
Signal category
Strategy & Corporate Development
Quote
“announcing the signing of a licensing agreement with Esserre to introduce Armolipid® Cholesterol Plus”
— Cooper Consumer Health team
Company
Cooper Consumer Health
Empowering Healthier Living 💛
- Industry
- Pharmaceutical Manufacturing
- Location
- Paris, FR
- Company size
- 1,338 employees
Cooper Consumer Health has grown into Europe's largest independent pure-play selfcare platform, serving millions of people. We develops, manufactures and distributes a broad portfolio of self-care brands and serves more than 100,000 pharmacies and drugstores across Europe and beyond. With an extensive commercial footprint, proven operational capabilities and dedicated local teams, Cooper Consumer Health help people take charge of people's health with effective, trusted solutions; guided by the belief that brighter health leads to a stronger you.